GVAX in Advanced Prostate Cancer Patients Made Lymphopenic
NCT00122005
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
BIOLOGICAL:
GM-CSF gene transduced allogeneic vaccine GVAX
Sponsor
Providence Health & Services
Collaborators
[object Object]
[object Object]